Bottom line
SPXS vs LABD: the short answer
SPXS (Direxion Daily S&P 500(R) Bear 3X ETF) and LABD (Direxion Daily S&P Biotech Bear 3X ETF) have nearly the same top holdings — their top 25 positions are about 93% the same by weight.
SPXS is cheaper at 1.04% vs 1.07% — a difference of $3.00 a year per $10,000 invested.
Over five years, SPXS returned −36.5% a year vs −37.7% for LABD.
Updated Nov 19, 2026
SPXS vs LABD side by side
| SPXS | LABD | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Direxion | Direxion |
| Category | Leveraged & Inverse | Leveraged & Inverse |
| Expense ratio | 1.04% | 1.07% |
| Annual cost per $10k | $104 | $107 |
| 10-yr cost on $10k (prospectus) | $1,271 | $1,316 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | −41.5% | −70.0% |
| 5-yr return (annualized) | −36.5% | −37.7% |
| 10-yr return (annualized) | −41.3% | −54.4% |
| Best quarter | +51.2% | +75.0% |
| Worst quarter | −51.2% | −75.2% |
| Net assets (fund) | $451.4M | $54.2M |
| Number of holdings | 11 | 10 |
| Portfolio turnover | % | % |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SPXS | LABD | Difference |
|---|---|---|---|
| 2025 | −41.5% | −70.0% | +28.5% |
| 2024 | −42.8% | −21.6% | −21.2% |
| 2023 | −45.9% | −41.6% | −4.3% |
| 2022 | +35.8% | −32.9% | +68.7% |
| 2021 | −58.0% | +2.1% | −60.2% |
| 2020 | −70.4% | −89.8% | +19.3% |
| 2019 | −56.6% | −70.6% | +14.0% |
| 2018 | +3.4% | −7.1% | +10.5% |
| 2017 | −44.5% | −75.6% | +31.2% |
| 2016 | −35.9% | −39.1% | +3.2% |
Source: Fund prospectus bar charts
Holdings overlap
11 of SPXS's top 11 holdings also appear in LABD's top 10.
| Holding | SPXS | LABD |
|---|---|---|
| Dreyfus | 35.74% | 40.47% |
| Goldman Financial | 30.50% | 52.74% |
| Dreyfus | 10.31% | 18.03% |
| Goldman Sachs Liq Es Fd A | 10.02% | 26.30% |
| N/a | -0.11% | -6.37% |
| N/a | -0.76% | -6.37% |
| N/a | -0.99% | -6.37% |
| N/a | -1.51% | -6.37% |
| N/a | -1.51% | -6.37% |
| N/a | -1.89% | -6.37% |
| N/a | -1.98% | -6.37% |
Source: SEC Form N-PORT
SPXS top 10
- Dreyfus — 35.74%
- Goldman Financial — 30.50%
- Dreyfus — 10.31%
- Goldman Sachs Liq Es Fd A — 10.02%
- N/a — -0.11%
- N/a — -0.76%
- N/a — -0.99%
- N/a — -1.51%
- N/a — -1.51%
- N/a — -1.89%
LABD top 10
- Goldman Financial — 52.74%
- Dreyfus — 40.47%
- Goldman Sachs Liq Es Fd A — 26.30%
- Dreyfus — 18.03%
- N/a — 2.98%
- N/a — 1.43%
- N/a — -1.55%
- N/a — -4.11%
- N/a — -4.88%
- N/a — -6.37%
FAQ
What is the difference between SPXS and LABD?
Which is cheaper, SPXS or LABD?
Should I own both SPXS and LABD?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.